Why the study?
Can noninvasive markers reliably determine vessel patency in patients with acute myocardial infarction compared to coronary angiography?
Can noninvasive markers reliably determine vessel patency in patients with acute myocardial infarction compared to coronary angiography?
Answers are grounded in this paper and cite their sources.
Emerging noninvasive markers may provide a reliable and rapid alternative to routine coronary angiography for assessing vessel patency in acute myocardial infarction.
For patients with acute myocardial infarction, the presence of a patent infarct-related coronary artery may be the most sensitive single predictor of clinical outcome and patient survival. Coronary angiography is the most direct means of assessing reperfusion status; however, availability, cost, and risk are potential concerns. Noninvasive markers are emerging which can reliably and rapidly determine vessel patency, circumventing the need for routine angiography.
No takes yet. Share an insight, caveat, or question.
R C Becker (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: